Cumberland Pharmaceuticals Inc (CPIX) bonds
CPIXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 10/30
$5.88−0.75 (-11.31%)
Close on Nov 13, 2026Market cap $88.10MP/E 1.3Yield –
Debt
Borrowings on the balance sheet, Sep 30, 2026
Cumberland Pharmaceuticals reports no long-term debt line
Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.
Notes and loans outstanding
As tagged in Cumberland Pharmaceuticals's 10-Q for the period ended Mar 31, 2026
Cumberland Pharmaceuticals's filings do not break debt down by note
The debt footnote in the annual report has no machine-readable detail for individual notes, so coupons and maturities cannot be listed.
Credit facilities
Revolving credit lines and other committed borrowing capacity
| Facility | Size | Drawn |
|---|---|---|
| Initial Revolving Credit Loan Agreement | $15.00M | – |
| Line of Credit | $15.00M | $5.20M |
| Revolving Credit Facility | $20.00M | – |
| Revolving Credit Facility | – | $5.20M |
| Revolving Credit Loan Agreement | $25.00M | – |
See a number that looks wrong?